In vitro transfection of anti-tumor miR-101 induces BIM, a pro-apoptotic protein, expression in acute myeloid leukemia (AML)

Acute myeloid leukemia (AML) frequently relapses after initial treatment, though it is possible that drug resistance occurs. Hence, it seems necessary to develop novel therapies such as gene therapy specifically via miRNA transfection. MicroRNA-101 has been considered as a tumor suppressor in different types of cancer. It is demonstrated that exogenous miR-101 transfection is associated with decreased viability in AML in this paper. Besides, the increase of pro-apoptotic protein BIM expression in both mRNA and protein level has been illustrated. The recent findings provide an insight into the novel function of miR-101 in AML by activating BIM as an important mediator in intrinsic apoptosis pathways. Generally, miR-101 has been considered as a therapeutic target in our data and might have a valuable role in AML.

• Publication year

  2017

• Venue

  EXCLI Journal : Experimental and Clinical Sciences

• Publication date

  2017-11-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.17179/excli2017-721PMID 29333128PMCID 5763080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting MicroRNAs in Cancer Gene Therapy

  2017cited by this paper
• From ATP synthase dimers to C-ring conformational changes: unified model of the mitochondrial permeability transition pore

  2017cited by this paper
• Anti-microRNA targeting using peptide-based nanocomplexes to inhibit differentiation of human pancreatic stellate cells.

  2017cited by this paper
• A miRNA-101-3p/Bim axis as a determinant of serum deprivation-induced endothelial cell apoptosis

  2017cited by this paper
• Welcome to volume 12 of Nanomedicine.

  2017cited by this paper
• miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma

  2016cited by this paper
• MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9

  2016cited by this paper
• The role of MicroRNAs in human cancer

  2016cited by this paper
• Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.

  2015cited by this paper
• Gene therapy for cancer: regulatory considerations for approval

  2015cited by this paper
• Optomizing Transfection Efficiency of Cervical Cancer Cells Transfected by Cationic Liposomes LipofectamineTM2000.

  2015cited by this paper
• Gene therapy for cancer: present status and future perspective

  2014cited by this paper
• AAV empty capsids: for better or for worse?

  2014cited by this paper
• miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.

  2014cited by this paper
• Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer.

  2014cited by this paper
• Advanced nanovehicles for cancer management.

  2014cited by this paper
• MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

  2014cited by this paper
• MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.

  2014cited by this paper
• MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells.

  2013cited by this paper
• The BH3-only protein Bim(L) overrides Bcl-2-mediated apoptosis resistance in melanoma cells.

  2013cited by this paper
• microRNAs as pharmacological targets in cancer.

  2013cited by this paper
• MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.

  2013cited by this paper
• Gene Delivery by Liposomes

  2013cited by this paper
• Bim, a Proapoptotic Protein, Up-regulated via Transcription Factor E2F1-dependent Mechanism, Functions as a Prosurvival Molecule in Cancer*

  2012influential reference
• A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells

  2012cited by this paper
• MiR-101 and Mcl-1 in non-small-cell lung cancer: expression profile and clinical significance

  2012cited by this paper
• miRNA-101: a potential target for tumor therapy.

  2012cited by this paper
• Up-regulation of Pro-apoptotic Protein Bim and Down-regulation of Anti-apoptotic Protein Mcl-1 Cooperatively Mediate Enhanced Tumor Cell Death Induced by the Combination of ERK Kinase (MEK) Inhibitor and Microtubule Inhibitor*

  2012cited by this paper
• Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia.

  2012cited by this paper
• Therapeutic advances in acute myeloid leukemia.

  2011influential reference
• Apoptosis and oncogenesis: give and take in the BCL-2 family.

  2011cited by this paper
• Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.

  2011cited by this paper
• MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2

  2011cited by this paper
• Chitosan conjugated DNA nanoparticles in gene therapy

  2010cited by this paper
• Differential expression of specific microRNA and their targets in acute myeloid leukemia

  2010cited by this paper
• MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.

  2009cited by this paper
• Gene therapy for cancer treatment: past, present and future.

  2006cited by this paper
• Acute myeloid leukemia: therapeutic impact of epigenetic drugs.

  2005cited by this paper

• The Role of Long Noncoding RNAs in Progression of Leukemia: Based on Chromosomal Location.

  2024cites this paper
• Multifunctional targetable liposomal drug delivery system in the management of leukemia: Potential, opportunities, and emerging strategies.

  2023cites this paper
• Association of miR-146a and miR196a2 genotype with susceptibility to idiopathic recurrent pregnancy loss in Iranian women: A case-control study

  2021cites this paper
• Trdmt1 3'-untranslated region functions as a competing endogenous RNA in leukemia HL-60 cell differentiation

  2020cites this paper
• Focused screening reveals functional effects of microRNAs differentially expressed in colorectal cancer

  2019cites this paper
• MicroRNA-101 inhibits autophagy to alleviate liver ischemia/reperfusion injury via regulating the mTOR signaling pathway

  2019cites this paper
• MicroRNA-101 inhibits autophagy to alleviate liver ischemia/reperfusion injury via regulating the mTOR signaling pathway

  2019cites this paper
• MiRNA -101 transfection and its effect on the cytotoxicity induction and expression of ubiquitin ligase HECTH9 in acute myeloid leukemia cells (AML)

  2018cites this paper